|
Report Date : |
03.08.2012 |
IDENTIFICATION DETAILS
|
Name : |
Beijing Double-Crane Pharmaceutical Equipment Co., Ltd. |
|
|
|
|
Registered Office : |
No. 33 Jinyuan Road, Industrial
Development Zone, Daxing District, Beijing
102628 PR |
|
|
|
|
Country : |
China |
|
|
|
|
Financials (as on) : |
31.12.2011 |
|
|
|
|
Date of Incorporation : |
01.01.1988 |
|
|
|
|
Com. Reg. No.: |
110106002048250 |
|
|
|
|
Legal Form : |
One-Person Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacturing and selling pharmaceutical equipment. |
|
|
|
|
No. of Employees : |
137 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
China |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Beijing Double-Crane Pharmaceutical
Equipment Co., Ltd.
no. 33
jinyuan road, industrial development zone, daxing district
beijing
102628 PR CHINA
TEL: 86
(0) 10-61273322/61271308
FAX: 86
(0) 10-61271208
Date of Registration : January 1, 1988
REGISTRATION NO. : 110106002048250
LEGAL FORM : One-person Limited Liability Company
REGISTERED CAPITAL : cny 17,777,800
staff : 137
BUSINESS CATEGORY : manufacturing
Revenue :
CNY 68,499,000 (AS OF DEC. 31, 2011)
EQUITIES :
CNY 45,082,000 (AS OF DEC. 31, 2011)
WEBSITE : www.bjdcpe.com
E-MAIL :
N/A
PAYMENT : AVERAGE
MARKET CONDITION : average
FINANCIAL CONDITION : stable
OPERATIONAL TREND : fairly STEADY
GENERAL REPUTATION : AVERAGE
EXCHANGE RATE : CNY 6.39 = USD
Adopted abbreviations (as follows)
SC - Subject Company
(the company inquired by you)
N/A – Not available
CNY – China Yuan Ren
Min Bi
This section aims at indicating the relative positions of SC in respect
of its operational trend & general reputation
Operational Trend:- General
Reputation:-
Upward Excellent
Steady Good
Fairly Steady Fairly
Good
Ordinary Average
Fair Fair
Stagnant Detrimental
Downward Not
known
Not known Not
yet be determined
Not yet be determined
SC was
established as one-person limited liability company of PRC with State
Administration of Industry & Commerce (SAIC) under registration No.: 110106002048250.
SC’s Organization Code Certificate
No.: 10110793-1

SC’s registered capital: cny 17,777,800
SC’s paid-in capital: cny 17,777,800
Registration Change Record:-
No significant changes of SC have
been noted in SAIC since its incorporation.
Current Co search indicates SC’s shareholders & chief
executives are as follows:-
|
Name of Shareholder (s) |
% of Shareholding |
|
Beijing Double-Crane
Pharmaceutical Co., Ltd. |
100 |
SC’s Chief Executives:-
|
Position |
Name |
|
Legal Representative,
Chairman, and General Manager |
Ge
Zhiyong葛智勇 |
No recent development was found during our checks at present.
Beijing Double-Crane Pharmaceutical
Co., Ltd.
100
------------------------------------
Beijing Double-Crane Pharmaceutical Co.,
Ltd. (DCPC) was jointly established by six legal shareholders on May 15th 1997
and was successfully listed on May 22nd of the same year (Share Code: 600062).
Date of Registration: May 16, 1997
Registration No.: 110000005103198
Legal Form: Shares Limited
Company
Registered Capital: CNY 571,696,000
Address: No. 1, Li Ze East 2nd Road, Wang
Jing Area, Chao Yang District, Beijing, PRC
Tel: +86 010 64742227-681
Fax: +86 010 64399089
E-mail: dawsonz@dcpc.com
Web: www.dcpc.com
Ge
Zhiyong, Legal Representative,
Chairman and General Manager
-------------------------------------------------------------------------------------------------------
Ø
Gender: M
Ø
Age: 48
Ø
Qualification:
EMBA
Ø
Working
experience (s):
At present, working in SC as legal representative,
chairman and general manager, also working in Beijing
Double-Crane Pharmaceutical Co., Ltd. as deputy general manager, working in
Beijing Double-Crane Purification Equipment Installation Co., Ltd. as legal
representative
SC’s registered business scope includes manufacturing
medicine production line, blister packaging machine, cartoning machine,
infusion production line; installing instrumentation, refrigeration equipment,
air purification equipment, plastic products, glass container; home furnishing
decoration; importing and exporting goods and technology, import and export
agent.
SC is
mainly engaged in manufacturing and selling pharmaceutical equipment.
Brand: Double-Crane
SC’s
products mainly include: blister packing machine,
cartoner, onitment filling tube and sealing machine, etc.
SC sources its materials 100% from domestic market. SC sells 70% of its products in domestic market, and 30% to overseas market, mainly Mid East, Southeast Asia, etc.
The buying
terms of SC include Check, T/T and Credit of 30-60 days. The payment terms of
SC include T/T, L/C and Credit of 30-60 days.
*Major Customer:
=============
Beijing
Double-Crane Pharmaceutical Co., Ltd.
Staff & Office:
--------------------------
SC is
known to have approx. 137 staff
at present.
SC owns an area as
its operating office & factory of approx. 36,600 sq. meters at the heading
address.
SC is known to have a
subsidiary at present:
n
Beijing Double-Crane Purification Equipment Installation Co., Ltd.
---------------------------------------------------------------------------------------
Date of Registration: November 6, 2003
Registration No.: 110106006249746
Legal Form: One-Person Limited
Liability Company
Registered Capital: CNY 3,000,000
Overall payment appraisal:
( ) Excellent ( ) Good (X) Average ( ) Fair ( ) Poor ( ) Not yet be determined
The appraisal serves as a reference to reveal SC's payments habits and ability
to pay. It is based on the 3 weighed
factors: Trade payment experience (through current enquiry with SC's
suppliers), our delinquent payment and our debt collection record concerning
SC.
Trade payment experience: SC did not
provide any name of trade/service suppliers and we have no other sources to
conduct the enquiry at present.
Delinquent payment record: None in our
database.
Debt collection record: No overdue amount
owed by SC was placed to us for collection within the last 6 years.
The bank
information of SC is not filed in SAIC.
Financial Summary
|
Unit: CNY’000 |
As
of Dec. 31, 2011 |
|
Long term investment |
3,000 |
|
Total assets |
88,357 |
|
|
------------- |
|
Long term liabilities |
1,410 |
|
Total
liabilities |
43,275 |
|
Equities |
45,082 |
|
|
------------- |
|
Revenue |
68,499 |
|
Profit before
tax |
4,489 |
|
Less: profit tax |
640 |
|
Profits |
3,849 |
Note: The detailed financials for Y2011 of SC are not filed in SAIC.
Important Ratios
=============
|
|
As
of Dec. 31, 2011 |
|
*Liabilities
to assets |
0.49 |
|
*Net profit
margin (%) |
5.62 |
|
*Return on
total assets (%) |
4.36 |
|
*
Revenue/Total assets |
0.78 |
PROFITABILITY:
AVERAGE
l
The revenue of SC appears
average in its line.
l
SC’s net profit margin is fairly good.
l
SC’s return on total assets is fairly good.
LIQUIDITY:
AVERAGE
l
SC’s revenue is in a
fair level, comparing with the size of its total assets.
LEVERAGE:
AVERAGE
l
The debt ratio of SC is average.
l
The risk for SC to go bankrupt is average.
Overall financial
condition of the SC: Stable.
SC is considered medium-sized in its line with
stable financial conditions.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.77 |
|
|
1 |
Rs.86.74 |
|
Euro |
1 |
Rs.68.31 |
INFORMATION DETAILS
|
Report Prepared
by : |
PDT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.